Last $2.08 USD
Change Today 0.00 / 0.00%
Volume 18.8K
GNVC On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for genvec inc (GNVC)

Year over year, GenVec, Inc. has seen revenues shrink from $9.4M USD to $3.7M USD, though the company was able to grow net income from a loss of $14.1M USD to a smaller loss of $10.0M USD. A reduction in the percentage of sales devoted to cost of goods sold from 153.41% to 149.16% was a key component in the bottom line growth in the face of falling revenues.
Currency in
Millions of US Dollars
As of:Dec 31
2010
Dec 31
2011
Restated
Dec 31
2012
Reclassified
Dec 31
2013
4 Year
Trend
Revenues16.517.79.43.7
TOTAL REVENUES16.517.79.43.7
Cost of Goods Sold----14.35.5
GROSS PROFIT16.517.7-5.0-1.8
Selling General & Admin Expenses, Total7.87.87.86.8
R&D Expenses20.917.4----
OTHER OPERATING EXPENSES, TOTAL28.725.27.86.8
OPERATING INCOME-12.2-7.5-12.8-8.6
Interest and Investment Income0.00.00.0--
NET INTEREST EXPENSE0.00.00.0--
Other Non-Operating Income (Expenses)0.3----0.0
EBT, EXCLUDING UNUSUAL ITEMS-11.9-7.4-12.8-8.6
Merger & Restructuring Charges-----0.7-1.5
Gain (Loss) on Sale of Assets------0.3
Other Unusual Items, Total-0.4---0.6-0.2
Other Unusual Items-0.4---0.6--
EBT, INCLUDING UNUSUAL ITEMS-12.3-7.4-14.1-10.0
Earnings from Continuing Operations-12.3-7.4-14.1-10.0
NET INCOME-12.3-7.4-14.1-10.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-12.3-7.4-14.1-10.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-12.3-7.4-14.1-10.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GNVC:US $2.08 USD 0.00

GNVC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Advaxis Inc $3.88 USD +0.15
Argos Therapeutics Inc $9.39 USD +0.57
Genocea Biosciences Inc $12.81 USD +0.46
Vical Inc $1.24 USD 0.00
ZIOPHARM Oncology Inc $3.23 USD +0.08
View Industry Companies
 

Industry Analysis

GNVC

Industry Average

Valuation GNVC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 8.6x
Price/Book 2.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 5.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENVEC INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.